{
  "main_header": {
    "sid": 539063,
    "name": "Brooks Lab.",
    "stock_name": "Brooks Lab.",
    "full_name": "Brooks Laboratories Ltd",
    "name_url": "stocks-analysis/brooks-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "60.95",
    "chg": 0.1,
    "chgp": "0.16%",
    "dir": 1,
    "prev_price": "60.85",
    "mcapval": "179.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 533543,
    "symbol": "BROOKS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE650L01011",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "16.08 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/brooks-lab-539063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Brooks Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-sell-4000686",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BrooksLaborator_mojoScore_4000686.png",
        "date": "2026-05-20 10:10:56",
        "description": "Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Brooks Laboratories Ltd Locks at Upper Circuit With 4.53% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-upper-circuit-amid-strong-buying-pressure-3999181",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BrooksLaborator_stocks_hitting_upper_circuit_3999181.png",
        "date": "2026-05-19 14:00:07",
        "description": "At Rs 48.42, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.53% on 19 May 2026, with buyers queuing and no sellers willing to part with shares."
      }
    ],
    "total": 15,
    "sid": "539063",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/brooks-laboratories-539063"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Aug-2026",
      "details": "Newspaper Advertisement - Intimation of 24th Annual General Meeting of the Company through VC/OAVM.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Under Regulation 29 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)",
      "datetime": "06-Aug-2026",
      "details": "Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve and take on record the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026 alongwith Limited Review Report thereon.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "17-Jul-2026",
      "details": "Appointment of Mr. Rajesh Mahajan as President - Trading.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Brooks Laboratories Ltd has announced <strong>1:16</strong> rights issue, ex-date: 28 Jul 23",
          "dt": "2023-07-28",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Brooks Laboratories Ltd is Rated Sell

2026-05-20 10:10:56

Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read More

Brooks Laboratories Ltd Locks at Upper Circuit With 4.53% Gain — Buyers Queue, Sellers Absent

2026-05-19 14:00:07

At Rs 48.42, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.53% on 19 May 2026, with buyers queuing and no sellers willing to part with shares.

Read More

View All News